WallStreetZenWallStreetZen

NASDAQ: FOLD
Amicus Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Amicus Therapeutics earnings were -$56.1M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest FOLD earnings report on Dec 31, 2024 announced Q4 2024 earnings of $14.7M, down 319% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, FOLD reported annual earnings of -$56.1M, with -63% growth. The next FOLD earnings date is May 7, 2025.

FOLD earnings history

Current Revenue
$528.3M
Current Earnings
-$56.1M
Current Profit Margin
-10.6%

FOLD Return on Equity

Current Company
-35.3%
Current Industry
-1.4%
Current Market
34.2%
FOLD's Return on Equity (-35.3%)... subscribe to Premium to read more.
High Return on Equity Performance

FOLD undefined

Current Company
-7.4%
Current Industry
0.2%
FOLD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when FOLD announces earnings.

FOLD undefined

Current Company
3.28%
Current Industry
6.7%
FOLD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

FOLD vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
FOLD$29.39M-$56.11MN/A-$0.18
NAMS-$254.20M-$254.31MN/A-$2.70
RXRX-$411.68M-$463.66MN/A-$1.69
VCYT$54.16M$24.14MN/A$0.32
MLTX-$119.58M-$121.24MN/A-$1.89
View Top Biotech Stocks

FOLD earnings dates

Next earnings date
May 7, 2025

Amicus Therapeutics Earnings Reports & History FAQ

What were Amicus Therapeutics's earnings last quarter?

On FOLD's earnings call on Invalid Date, Amicus Therapeutics (NASDAQ: FOLD) reported Q4 2024 earnings per share (EPS) of $0.05, up 145.45% year over year. Total FOLD earnings for the quarter were $14.74 million. In the same quarter last year, Amicus Therapeutics's earnings per share (EPS) was -$0.11.

If you're new to stock investing, here's how to buy Amicus Therapeutics stock.

When does Amicus Therapeutics report earnings?

The next FOLD earnings date is Invalid Date. Add FOLD to your watchlist to be reminded of Amicus Therapeutics's next earnings date.

Is Amicus Therapeutics profitable or losing money?

As of the last Amicus Therapeutics earnings report, Amicus Therapeutics is currently losing money. Amicus Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$56.11 million, a 62.99% decrease year over year.

What was FOLD's earnings growth in the past year?

As of Amicus Therapeutics's earnings date in Invalid Date, Amicus Therapeutics's earnings has grown year over year. FOLD earnings in the past year totalled -$56.11 million.

What are Amicus Therapeutics's earnings expectations?

The current EPS estimate for Amicus Therapeutics's earnings report in Invalid Date is -$0.07.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.